Building a Diagnostic Rule for Acute Heart Failure in Emergency Departments
Builds a rule to help diagnose acute heart failure in emergency patients.
Key facts
- Who runs it
- Chinese University of Hong Kong
- Where
- Hong Kong, Hong KongSee the 3 sites
- Trial code
- Registry title
- Comprehensive Clinical Prediction Rule for Acute Heart Failure
- Status
- Recruiting
- People taking part
- 560 people, planned
- Started
- 17 Aug 2026
- Expected to end
- 31 Jan 2029
- Type of study
- Observational, 2 groups
- Treatments tested
- Acute Heart Failure Diagnostic Method
- Record updated
- 5 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who come to the emergency department with suspected acute heart failure or sudden shortness of breath. It tests a combined way to diagnose acute heart failure.
- Age
- 18 years and older
- Sex
- All sexes can join.
- Disease stage
- Suspected acute heart failure or acute shortness of breath (dyspnea). Symptoms include shortness of breath, swollen legs, difficulty breathing when lying flat, waking at night short of breath, breathlessness on exertion, or weight gain.
Main reasons for not taking part
- Trauma patients
- Pregnancy
- Unstable patients who need invasive airway treatment
- Patients who refuse to take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Adult (aged ≥ 18 years)
- Suspected AHF or acute dyspnea
- Symptoms include shortness of breath, swelling of legs, orthopnea, paroxysmal nocturnal dyspnoea, exertional dyspnea or weight gain
Who cannot take part
- Trauma patients
- Pregnancy
- Unstable patients requiring invasive airway intervention
- Patients who refuse to participate
Where in Hong Kong
- Prince of Wales HospitalHong Kong, Hong KongContact: Theresa HuiTaking people
- Queen Mary HospitalHong Kong, Hong KongContact: Rex PK Lam, Dr.Not yet recruiting
- Tuen Mun HospitalHong Kong, Hong KongContact: Jeffrey HT Fung, Dr.Not yet recruiting
About the trial
What the trial wants to find out
The goal of this prospective observational cohort study is to establish a comprehensive clinical prediction rule integrating clinical characteristics, point-of-care testing (POCT) of NT-proBNP, an 8-point LUS, and a rapid cardiac assessment using bedside echocardiography for diagnosing acute heart failure (AHF) in the emergency department. A clinical prediction rule with high diagnostic accuracy will minimize delays and misdiagnoses, as well as the potential harm they may cause to patients. The primary outcome measure is the adjudicated AHF diagnosis. Secondary outcome measures include ED and discharge diagnosis of the patients.
The 2 groups in the trial
- Testing Cohort
Patients from PWH and TMH
Treatment: Acute Heart Failure Diagnostic Method
- Validation Cohort
Patients from QMH
Treatment: Acute Heart Failure Diagnostic Method
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Establishing a Comprehensive Clinical Prediction Rule for the Diagnosis of Acute Heart Failure in the Emergency Department
- Plain-language title
- Building a Diagnostic Rule for Acute Heart Failure in Emergency DepartmentsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 13 November 2026.
- Record updated
- 5 November 2026